CereVasc Announces First Patient Randomized to eShunt® System Treatment in STRIDE Pivotal Trial
CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced ...
Endovascular Today3d
CereVasc STRIDE Trial Randomizes First Patient to eShunt System
CereVasc, Inc. announced the randomization of the first patient in the multicenter STRIDE clinical trial of the company’ ...
MassDevice3d
CereVasc randomizes first patient in head-to-head study of eShunt, standard of care
CereVasc today announced the first patient randomized to and treated with the eShunt system in its STRIDE clinical trial.
jnis.bmj4d
Online First
Rising tide of middle meningeal artery embolization for chronic subdural hematomas: current volumes and future growth compared with cerebral aneurysm and stroke interventions ...